Back
Product details:
CAS
19171-19-8
Purity
95%
Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. It is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib.
Properties
Name
Pomalidomide
Smiles
NC=1C=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C21
Targets
Please log in to see this information
SDS
1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline | 3-amino-N-(2,6-dioxo-3-piperidinyl) phthalimide | 4-amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxo-piperidin-3-yl)-isoindole-1,3-dione | 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | CC-4047 | Pom | Pomalyst | pomalidomide
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline | 3-amino-N-(2,6-dioxo-3-piperidinyl) phthalimide | 4-amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxo-piperidin-3-yl)-isoindole-1,3-dione | 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | CC-4047 | Pom | Pomalyst | pomalidomide
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.